ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT
Report
- Report Number
- 3002808486-2025-00131
- Event Type
- Death
- Date Received
- June 12, 2025
- Date of Event
- November 20, 2020
- Report Date
- July 3, 2025
- Manufacturer
- WILLIAM COOK EUROPE
- Product Code
- MIH
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
MANUFACTURERS REF#: (B)(4). BASED ON RESPONSE RECEIVED TO REQUESTED INFORMATION FROM THE SITE IT IS CONCLUDED THAT THERE ARE NO INDICATIONS THAT THE ZTA DEVICES ARE IMPLICATED IN THE EVENT OR THAT THE PROCEDURE IS RELATED TO THE DEATH AND THEREBY THE EVENT IS NO LONGER CONSIDERED REPORTABLE. COOK MEDICAL WILL CONTINUE TO MONITOR FOR SIMILAR EVENTS. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803. THIS REPORT IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT MADE IN IT IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED; THAT A DEATH OR SERIOUS INJURY OCCURRED; OR THAT ANY COOK DEVICE CAUSED OR CONTRIBUTED TO; OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.
MANUFACTURERS REF# (B)(4). BLANK FIELDS ON THIS FORM INDICATE THE INFORMATION IS UNKNOWN OR UNAVAILABLE. D4) CATALOG #: ZTA-PT-42-38-225 AND ZTA-PT-38-34-217. D4) LOT #: E3943633 AND E3953730. G4) SIMILAR TO DEVICE MARKETED UNDER 510(K)/PMA: P140016. INVESTIGATION IS STILL IN PROGRESS. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803. THIS REPORT IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT MADE IN IT IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED; THAT A DEATH OR SERIOUS INJURY OCCURRED; OR THAT ANY COOK DEVICE CAUSED OR CONTRIBUTED TO; OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.
NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
DESCRIPTION OF EVENT ACCORDING TO STUDY (B)(6): ZENITH ALPHA THORACIC POST MARKET RETROSPECTIVE STUDY): SYNOPSIS: THE PATIENT EXPERIENCED HEMORRHAGE/HEMORRHAGIC SHOCK 18 DAYS POST-PROCEDURE AND DIED 27 DAYS POST-PROCEDURE. ON (B)(6) 2020, THIS 79-YEAR-OLD MALE PATIENT WAS ROUTINELY TREATED FOR CHRONIC THORACIC AORTIC DISSECTION TYPE B WITH PLACEMENT OF A PROXIMAL ZTA-PT-42-38-225 AND A DISTAL ZTA-PT-38-34-217, STARTING AT ZONE 2. ON (B)(6) 2020, THE PATIENT EXPERIENCED HEMORRHAGE/HEMORRHAGIC SHOCK. THE EVENT WAS TREATED WITH ANTIBIOTICS, INOTROPIC CARDIAC SUPPORT, AND OXYGEN. THE EVENT LED TO DEATH. THE SITE NOTED THE RELATIONSHIP OF THE EVENT TO THE STUDY DEVICE, PROCEDURE, AND TREATED AORTIC DISEASE AS ¿RETROSPECTIVE EVENT, UNABLE TO DETERMINE. PATIENT OUTCOME: ON (B)(6) 2020, THE PATIENT DIED. THE CAUSE OF DEATH WAS HEMORRHAGIC SHOCK. DESCRIPTION OF CIRCUMSTANCES INCLUDES ¿PCR COVID 19 POSITIVE.¿ RELATIONSHIP ASSESSMENT OF DEATH TO STUDY DEVICE AND PROCEDURE WAS NOT PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1669400 | ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT | MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | WILLIAM COOK EUROPE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Male | Death |